|
Originally published In Press as doi:10.1074/jbc.M105975200 on September 18, 2001
J. Biol. Chem., Vol. 276, Issue 48, 45330-45340, November 30, 2001
The Plasma Membrane-associated Protein RS1 Decreases
Transcription of the Transporter SGLT1 in Confluent
LLC-PK1 Cells*
Thomas
Korn ,
Thomas
Kühlkamp ,
Christina
Track,
Irina
Schatz,
Katharina
Baumgarten,
Valentin
Gorboulev, and
Hermann
Koepsell§
From the Institute of Anatomy of the Bayerische
Julius-Maximilians-Universität,
97070 Würzburg, Germany
Received for publication, June 27, 2001, and in revised form, September 5, 2001
 |
ABSTRACT |
Previously we cloned RS1, a 67-kDa polypeptide
that is associated with the intracellular side of the plasma membrane.
Upon co-expression in Xenopus laevis oocytes, human RS1
decreased the concentration of the
Na+-D-glucose co-transporter hSGLT1 in the
plasma membrane (Valentin, M., Kühlkamp, T., Wagner, K., Krohne,
G., Arndt, P., Baumgarten, K., Weber, W.-M., Segal, A., Veyhl, M., and
Koepsell, H. (2000) Biochim. Biophys. Acta 1468, 367-380).
Here, the porcine renal epithelial cell line LLC-PK1 was used to
investigate whether porcine RS1 (pRS1) plays a role in transcriptional
up-regulation of SGLT1 after confluence and in down-regulation of SGLT1
by high extracellular D-glucose concentrations. Western
blots indicated a dramatic decrease of endogenous pRS1 protein at the
plasma membrane after confluence but no significant effect of
D-glucose. In confluent LLC-PK1 cells overexpressing pRS1,
SGLT1 mRNA, protein, and methyl- -D-glucopyranoside uptakes were drastically decreased; however, the reduction of methyl- -D-glucopyranoside uptake after cultivation with
25 mM D-glucose remained. In confluent pRS1
antisense cells, the expression of SGLT1 mRNA and protein was
strongly increased, whereas the reduction of SGLT1 expression during
cultivation with high D-glucose was not influenced. Nuclear
run-on assays showed that the transcription of SGLT1 was 10-fold
increased in the pRS1 antisense cells. The data suggest that RS1
participates in transcriptional up-regulation of SGLT1 after confluence
but not in down-regulation by D-glucose.
 |
INTRODUCTION |
Because D-glucose has a key role in cellular
metabolism, organisms dispose of highly efficient mechanisms to control
transepithelial absorption of D-glucose in the small
intestine and kidney and the D-glucose uptake into
glucose-metabolizing cells. In the kidney and small intestine,
D-glucose is translocated across epithelial cells by the
consecutive operation of glucose transporters that belong to the
following two gene families: secondary active
Na+-D-glucose co-transporters of the SGLT
family in the brush-border membrane, and Na+-independent
glucose transporters of the GLUT family in the basolateral membrane (1,
2). The regulation of glucose transport affects transporters of both
families, is cell type-specific, and is brought about by various
mechanisms (1, 3). The regulation of glucose transport has pivotal
physiological and biomedical importance. For example (i) one of the
biological effects of insulin is the stimulation of
D-glucose uptake into fat cells by GLUT4 (4, 5). (ii) The
D-glucose absorption in small intestine is adapted to diet
by glucose-dependent regulation of the high affinity
Na+-D-glucose co-transporter SGLT1 (6, 7).
(iii) The capacity of the D-glucose reabsorption in the
proximal tubule is one of the factors that determined
D-glucose plasma levels in diabetic patients (8). (iv) The
glomerulosclerosis observed in diabetes may be explained by the
up-regulation of GLUT1 in mesangium cells, which triggers the
overproduction of matrix proteins (9, 10).
Regulation of SGLT1 has been studied in small intestine (7, 11-13), in
Xenopus oocytes (14), and in the renal epithelial cell line
LLC-PK1 which is derived from porcine kidney proximal tubule cells (15-22). One of the factors that affect the expression of
SGLT1 in small intestine and LLC-PK1 cells is extracellular D-glucose concentration (7, 17, 18). However, with
increasing D-glucose the expression of SGLT1 in small
intestine was increased, whereas it was decreased in
LLC-PK1 cells, and the regulatory specificity for SGLT1
remained ambiguous. Another factor observed in cell culture is cell
confluence. During confluence of LLC-PK1 cells,
up-regulation of SGLT1 was observed, together with other differentiation-specific gene products of kidney proximal tubules such
as tight junctions and brush-border enzymes (16, 19, 22-24). The
confluence-dependent regulation of SGLT1 in
LLC-PK1 cells appears to be mediated by protein kinases.
Before confluence, activity of protein kinase C is high, and the
mRNA level of SGLT1 is very low. After confluence, protein kinase C
is down-regulated, whereas protein kinase A is up-regulated, and the
level of SGLT1 mRNA is largely increased (19, 22, 24). One of the
effects of protein kinase A is to enhance message stability, mediated by a specific RNA-binding protein (20, 21, 25).
Some years ago, we cloned RS1, a hydrophilic 67-kDa polypeptide from
porcine kidney cortex that changed the expression of SGLT1 in
Xenopus oocytes (26). Preliminary immunohistochemical experiments suggested that RS1 is localized at the extracellular side
of the brush-border membrane and interacts specifically with SGLT1 (26,
27). Based on these findings, we put forward the hypothesis that RS1 is
a subunit of SGLT1. This hypothesis was recently abandoned because we
found that RS1 is actually localized at the intracellular face of the
plasma membrane and that overexpression of human RS1 in
Xenopus oocytes not only decreased the expression of human
SGLT1 but also that of the human organic cation transporter hOCT2 (28,
29). In the present study, LLC-PK1 cells were used to
investigate the putative role of RS1 in the regulation of SGLT1 expression and activity by cell confluence and extracellular glucose concentration. Evidence is provided that RS1 is involved in the confluence-dependent regulation of SGLT1 by decreasing the
expression of SGLT1 in nonconfluent LLC-PK1 cells via
down-regulation of mRNA transcription. A role of RS1 in the
glucose-dependent regulation of SGLT1 could not be detected.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture--
The porcine renal epithelial cell line
LLC-PK1 (15) was maintained in Dulbecco's modified
Eagle's medium (DMEM)1 that
contained 5 mM D-glucose and was supplemented
with 10% (v/v) fetal bovine serum, 5 mM
L-glutamine, 0.1 mg/ml streptomycin sulfate, and 100 units/ml penicillin G. In some experiments, D-glucose concentration was adjusted to 25 mM. Cells were grown at
37 °C on Petri dishes in the presence 5% (v/v) CO2, and
the culture medium was replaced every 2-3 days. When seeded at a
density of 104 cells/cm2, confluence was
reached in about 6 days. For passaging or transport measurements, the
cells were detached by incubation for 30 min at 37 °C in
Ca2+- and Mg2+-free Dulbecco's
phosphate-buffered saline (DPBS) that was supplemented with 28 mM NaHCO3, 0.5 mM EDTA, 10 mM Hepes, pH 7.4 (30). Subsequently cells were harvested,
pelleted by 3-min centrifugations at 250 × g, and
resuspended in culture medium or transport assay buffer.
Constructs for the Expression of Sense and Antisense
RS1--
For overexpression, porcine RS1 (pRS1) in pBluescriptII SK
plasmid (26) was restricted with BglII and
HindIII, filled in with Klenow polymerase, ligated to
BstXI adaptors, and inserted at the BstXI site of
the eucaryotic expression vector pRcCMV from Invitrogen (Leek,
Netherlands). The correct orientation of pRS1 was verified by
restriction analysis and DNA sequencing (pRcCMV-pRS1). For the
overexpression of antisense RS1 RNA, a 1481-bp fragment of pRS1
cDNA (nucleotides (nt) 1-1481, GenBankTM accession
number X64315), which encompassed the ATG translation initiation codon,
was ligated to BstX1 adaptors and inserted into the pRcCMV
vector. A correct RS1 antisense clone (pRcCMV anti-pRS1) was identified
by restriction analysis and DNA sequencing. Analogously, an 1845-bp
cDNA fragment of pRS1 (nt 1-1845) was cloned in reverse orientation into the pIND vector from Invitrogen (pIND anti-pRS1). The
pIND plasmid is under control of the minimal heat shock promoter (P HSP) and of a modified ecdysone response element. It
also confers the neomycin resistance gene. pIND anti-pRS1 was
co-transfected with the pVgRXR plasmid (Invitrogen) that encodes
receptors for ecdysone and retinoid X and contains a
ZeocinTM resistance gene. After co-transfection of
pIND-anti-RS1 with pVgRXR, the P HSP promoter is induced
when the cells are treated with muristerone A (31). Muristerone A binds
to ecdysone/retinoid X receptor heterodimers that subsequently interact
with a response element on the pIND vector, thereby activating the
transcription of antisense pRS1 RNA from the minimal heat shock
promoter (32). As another control for RS1 antisense experiments, the
porcine oxytocin receptor (nt 1-1184, GenBankTM accession
number X71796) was cloned in reverse orientation into the pRcCMV vector
(pRcCMV anti-oxytocin).
Stable Transfection of LLC-PK1 Cells--
Native
LLC-PK1 cells grown in DMEM were transfected with
pRcCMV-pRS1, pRcCMV anti-pRS1, the empty pRcCMV plasmid, pRcCMV
anti-oxytocin, or pIND anti-RS1 plus pVgEcR using Lipofectin reagent
from Life Technologies, Inc. After transfection, the cells were kept in DMEM for 2 days. Selection was initiated by adding geneticin (G418) to
the culture medium (0.4 mg/ml for 1 week and 0.8 mg/ml later). Single
clones were isolated after 3 weeks and amplified in DMEM containing 0.8 mg/ml G418. Genomic integration of the pRcCMV antisense pRS1 constructs
and their transcription were tested by polymerase chain reactions
(PCRs) without and with reverse transcription, respectively. The
employed primers were derived from the T7 region of the CMV promoter
(sense, 5'-TAA TAC GAC TCA CTA TAG GG-3') and from the cDNA
sequence of pRS1 (antisense, 5'-CTT AAT TCA GCA GGC GG-3', nt 793-809
(26)). For reverse transcriptase-PCR, a primer downstream from the T7
promoter (sense, 5'-GCT TGG TAC CGA GCT CGG-3') was used together with
the above described pRS1-specific antisense primer. In
LLC-PK1 cells transfected with pIND anti-RS1 plus pVgEcR,
transcription of pRS1 antisense mRNA was induced by cultivating the
cells for 2 days in the presence of 5 µM muristerone A.
Northern Analysis--
For Northern blots mRNA was isolated
from LLC-PK1 cells (33). In some experiments the
transcription was blocked by addition of
5,6-dichloro-1- -D-ribofuranosylbenzimidazole (DRB) to
culture medium. 5 µg of mRNA per lane were resolved on
glyoxal-agarose gels, blotted to Hybond-N membrane (Amersham Pharmacia
Biotech), cross-linked by UV irradiation, and hybridized to
double-stranded cDNA probes of various genes that were labeled with
[ -32P]dATP (34). The blots were stripped and reprobed
several times. The probes were derived from pRS1 (26) (nt 577-1680),
porcine Na+-D-glucose co-transporter pSGLT1
(17) (nt 1546-1818), human sodium-independent glucose transporter
hGLUT1 (35) (nt 1-2856), human polyspecific cation transporter hOCT2
(36) (nt 1-1703), porcine vasopressin receptor pV2R (37) (nt 1-1494),
human glyceraldehydephosphate dehydrogenase hGAPDH (1.1-kb fragment
from CLONTECH, Heidelberg, Germany), and human
ubiquitin (260-bp fragment from CLONTECH). For
porcine cDNA probes, the membranes were washed at a final stringency of 0.25× SSPE (0.18 mM NaCl, 10 mM
sodium phosphate, pH 7.7, 1 mM EDTA), 0.1% (w/v) SDS at
42 °C. For the human probes, 1× SSPE was used in the final
stringency buffer. In some experiments, the autoradiographic signals
detected on x-ray films were quantified by digitizing the stained bands
and subtracting the background staining (Sigmascan program from Sigma,
Deisenhofen, Germany).
Nuclear Run-on Transcription Assay--
The employed
experimental protocol was adapted from procedures described previously
(38, 39). LLC-PK1 cells were grown with 5 mM
D-glucose in the medium until 5 days after confluence, washed with phosphate-buffered saline (0.01 M
Na2HPO4, 0.15 M NaCl, pH 7.4),
harvested, and lysed with lysis buffer that consisted of 0.01 M Tris-HCl, pH 7.4, 3 mM MgCl2,
0.5% (w/v) Nonidet P-40, and 1 mM phenylmethylsulfonyl
fluoride (PMSF). The nuclei were spun down by a 5-min centrifugation at
4000 × g (4 °C), washed three times with lysis
buffer, and stored at 70 °C in 0.02 M Tris-HCl, pH
7.9, 0.075 M NaCl, 0.5 mM EDTA, 0.85 mM dithiothreitol, 0.125 mM PMSF, 50% (v/v)
glycerol, and 32 units/ml ribonuclease inhibitor. Transcription was
initiated by adding 107 nuclei to 100 µl of assay buffer
that contained 0.1 M Tris-HCl, pH 7.9, 0.05 M
NaCl, 0.4 mM EDTA, 0.34 M
(NH4)2SO4, 4 mM
MnCl2, 0.05 mM PMSF, 0.6 mM
dithiothreitol, 2 mM ATP, 2 mM GTP, 2 mM CTP, 250 µCi of [ -32P]UTP, 0.25 mg/ml
heparin sulfate, and 0.5 units/ml ribonuclease inhibitor. After 30 min
of incubation at 30 °C, the reaction was stopped by adding
RNase-free DNase and CaCl2 to final concentrations of 750 units/ml and 1 mM, respectively. Then proteinase K (0.5 mg/ml), yeast transfer RNA (0.33 mg/ml), SDS (1.5%), EDTA (10 mM), and Tris-HCl (15 mM, pH 7.4) were added,
and the mixture was incubated for 30 min at 45 °C. The labeled RNA
transcripts were isolated using 4 M guanidinium
isothiocyanate and phenol/chloroform extraction, followed by two
isopropyl alcohol precipitations. They were suspended in 200 µl of 20 mM Tris-HCl, pH 7.9, and 20 mM EDTA,
and the labeled RNA transcripts were quantified by -counting. As
hybridization templates, purified cDNA fragments were immobilized on nylon filters (pSGLT1, nt 1546-1818; hGAPDH, nt 197-806; hGLUT1, nt 1-2856; hOCT2, nt 1-1703; lac repressor lacI
of Escherichia coli, nt 123-1629). Per dot, 2 µg of cDNA fragment heated to 95 °C were applied to filters
and fixed by UV cross-linking plus 2 h of incubation at 80 °C.
The filters were prehybridized by 2 h of incubation at 42 °C
with 5× SSPE, 5× Denhardt's solution, 0.5% SDS, 50% formamide, 500 µg/ml yeast tRNA, and 100 µg/ml polyadenylic acid (hybridization
buffer). For hybridization, the filters were incubated for 20 h at
42 °C with hybridization buffer containing equal amounts of the
radioactively labeled mRNAs (25 × 107 cpm per
filter) that had been denatured (5 min, 65 °C). Washing was
performed one time for 15 min at 42 °C with 2× SSPE, 0.1% SDS, one
time for 30 min at 37 °C with 2× SSPE containing 10 µg/ml RNase
A, and one time for 30 min at 42 °C with 1× SSPE containing 0.1%
SDS. Filters were exposed for autoradiography to x-ray film for 7 days
at 70 °C.
Western Blotting--
Plasma membranes from LLC-PK1
cells were enriched by differential centrifugation as described
previously (40). Briefly, the cells were scraped with a rubber
policeman into ice-cold Hepes buffer (10 mM Hepes/Tris, pH
7.4, containing 30 mM mannitol, 10 mM
CaCl2, 0.5 mM PMSF, 1 mM
benzamidine, 5 µg/ml aprotinin, 5 µg/ml leupeptin), homogenized in
a Teflon potter, and incubated for 10 min on ice. Nuclei and cell
debris were removed by 15 min of centrifugation at 5000 × g at 8 °C. The supernatant, termed homogenate, was
centrifuged for 30 min at 40,000 × g at 8 °C. The
resulting pellet enriched in plasma membranes was termed PME (see
upper lane of Fig. 2a). Membrane-free cytosolic
proteins were prepared by centrifuging the 40,000 × g
supernatant for 2 h at 200 000 × g at 8 °C.
For SDS-polyacrylamide gel electrophoresis, protein samples were
incubated for 1 h at 37 °C in 50 mM
Na2HPO4, pH 6.8, 4 M urea, 0.25 M -mercaptoethanol, 1% (w/v) SDS, and 0.0005% (w/v)
bromphenol blue. If immunodetection of pRS1 was intended, the
SDS-treated protein samples were subsequently acetylated (29). After
SDS-polyacrylamide gel electrophoresis performed according to Laemmli
(41), the proteins were electrophoretically transferred to
nitrocellulose membranes by semi-dry blotting (42). The nitrocellulose
membranes were blocked for 1 h at 25 °C in blocking buffer (50 mM Tris-HCl, pH 8.0, containing 137 mM NaCl, 2.7 mM KCl, 0.05% (w/v) Tween 20, and 2% (w/v) skimmed
milk powder). For antibody reaction, the blots were incubated for
2 h at 25 °C with affinity-purified polyclonal rabbit
antibodies against porcine SGLT1 (pSGLT1-ab) or porcine RS1 (pRS1-ab)
that were diluted 1:10 or 1:2500 in blocking buffer, respectively. The
antibodies have been described earlier (29, 43). pSGLT1-ab are raised against the amino acids 525-542 of porcine SGLT1 and affinity-purified on the antigenic peptide fixed to Sepharose, whereas pRS1-ab was raised
against recombinant pRS1 protein expressed in E. coli and affinity-purified on the recombinant protein fixed to enzyme-linked immunosorbent assay plates. After washing the blots with the blocking buffer they were incubated for 1 h at 25 °C with
peroxidase-conjugated goat anti-rabbit IgG antiserum that was diluted
1:5000 in blocking buffer. Blots were then washed with blocking buffer,
and bound label was visualized by enhanced chemiluminescence (ECL
System from Amersham Pharmacia Biotech).
Measurements of Na+-D-Glucose
Co-transport Activity--
The procedure was adapted from Kimmich
et al. (30). LLC-PK1 cells were detached from
culture dishes by incubation for 20 min (37 °C, 5% CO2)
in Ca2+- and Mg2+-free DPBS. After 3 min of
centrifugation at 250 × g, the pelleted cells were
suspended at a protein concentration between 5 and 10 mg/ml in DPBS
(37 °C). Protein concentration was measured according to Bradford
(44). For transport measurements, this stock suspension was kept at
37 °C. Measurements were started by adding 50 µl of the stock
suspension into 200 µl of incubation medium that was shaken in a
37 °C water bath. The incubation medium consisted of DPBS containing
nonradioactive methyl- -D-glucopyranoside (AMG) plus 1.9 kBq of [14C]AMG. Nonspecific AMG uptake was measured in
the presence of 100 µM phlorizin. Because control
experiments showed that the uptake rate of 40 µM or 2 mM AMG was linear during an incubation period of more than
5 min, the cells were routinely incubated for 2.5 min at 37 °C. The
transport measurement was stopped by removing 200 µl of transport
assay mixture and adding it to 1 ml of ice-cold stop solution (DPBS
containing 1 mM phlorizin). The uptake at time 0 was
determined by adding the ice-cold stop solution together with the
respective amount of AMG. After 1 min of centrifugation at 8000 × g, the supernatant was removed; 1 ml of stop solution was
added, and the sample was centrifuged again. The supernatant was
carefully removed, and 100 µl of 0.5% (w/v) Triton X-100 were added.
The tubes were shaken for 1 h at room temperature; 1 ml of
Quickszint (LumasafeTMPlus, Groningen, Netherlands) was
added; the vial was closed, shaken vigorously, and counted in a
-counter.
Statistics--
Means ± S.D. of phlorizin inhibitable
uptake rates were calculated from uptake measurements that were
performed after 0 and 2.5 min of incubation of LLC-PK1
cells. For each individual uptake measurement, four independent
determinations were performed in the absence of phlorizin plus four
determinations in the presence of phlorizin. The Michaelis-Menten
equation was fitted to uptake rates determined for different substrate
concentrations. For densitometric quantifications of Northern blots and
nuclear run-on assays, three to four independent hybridizations were
used per each experimental condition, employing samples from two or
more independent cultivations. The unpaired Student's t
test was used to evaluate the significance of differences between
uptake rates or hybridization intensities.
Materials--
[ -32P]dATP (111 TBq/mmol) and
[ -32P]dUTP (29.6 TBq/mmol) were obtained from ICN
(Eschwege, Germany), [14C]AMG (11.25 GBq/mmol) from
Amersham Pharmacia Biotech, and ribonuclease inhibitor and RNase-free
DNase from Fermentas (St. Leon-Rot, Germany). Peroxidase-conjugated
anti-rabbit IgG from goat, RNase A, DRB, Dulbecco's phosphate-buffered
saline (DPBS), and polyadenylic acid were supplied by Sigma. Lipofectin
and prestained marker proteins for SDS-polyacrylamide gel
electrophoresis (BenchMarkTM) were supplied by Life
Technologies, Inc., geneticin (G418) by Calbiochem, and Bradford
protein assay by Bio-Rad. All other chemicals were obtained as
described earlier (26, 43).
 |
RESULTS |
Endogenous Expression of SGLT1 and RS1 in LLC-PK1
Cells--
LLC-PK1 cells were derived from porcine kidney
and exhibited properties similar to the S3 segment of the proximal
tubule (15). They normally expressed both SGLT1 and RS1 (17, 26).
Previously, it has been described (16-19) that the expression of SGLT1
in LLC-PK1 cells is up-regulated after confluence and
repressed during cultivation in the presence of high
D-glucose concentrations in the medium (25 versus 5 mM). As co-expression experiments of
RS1 with SGLT1 in Xenopus oocytes suggested
species-dependent up- or down-regulation of SGLT1 by RS1
(26, 29, 45), we investigated whether any alterations of pRS1
expression occur during the course of SGLT1 regulation by confluence
and glucose concentrations. By confirming previous data, we observed
that phlorizin-inhibitable uptake into subconfluent LLC-PK1
cells was very low and not significantly different after cultivation in
low versus high D-glucose. In cells that were
grown to about 60% confluence in the presence of 5 or 25 mM D-glucose, the phlorizin-inhibitable uptake
of 40 µM AMG was 0.46 ± 0.07 and 0.35 ± 0.14 pmol × mg protein 1 × min 1,
respectively (means ± S.D. of three independent experiments). After confluence, AMG uptake rates increased linearly for 5 days (data
not shown). When these cells were grown in 5 or 25 mM
D-glucose for 5 days upon reaching confluence, the initial
phlorizin-inhibitable uptake rates of 40 µM AMG were
140.4 ± 29.8 (n = 3) and 27.3 ± 3.4 (n = 3) pmol × mg 1 × min 1, respectively (means ± S.D. of three
independent experiments, p < 0.001 for difference,
81 ± 21% inhibition by cultivation with high glucose). The
Northern blots in Fig. 1 show that the
levels of SGLT1 mRNA were significantly increased after confluence
in cells grown in 5 mM D-glucose. In contrast,
in cells that were cultured in 25 mM D-glucose,
the mRNA of SGLT1 was not increased after confluence. Similar
effects were observed with the 3.9- and 2.2-kb transcripts of the
pSGLT1 gene. The two transcripts differ in length of
the 3'-untranslated region as a result of alternative polyadenylation
(17). In contrast to SGLT1, the concentrations of RS1 mRNA before
and after confluence were not significantly different in
LLC-PK1 cells grown in 5 mM
D-glucose. The mRNA level of RS1 also remained
unchanged irrespective of whether the cells were grown in 5 mM of 25 mM D-glucose (Fig. 1).

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 1.
Northern blot analysis of SGLT1 and RS1
mRNA in subconfluent and confluent native LLC-PK1 cells
grown in low or high D-glucose. Native
LLC-PK1 cells were grown on culture plates with 5 mM D-glucose (5G) or 25 mM D-glucose (25G). Two days before
confluence (subconfl.) and 5 days after confluence
(confl.), cells were harvested, and mRNA was isolated.
Northern blots were prepared and hybridized with a cDNA probe for
pSGLT1 (SGLT1), stripped, hybridized with a cDNA probe
for pRS1 (RS1), stripped again, and hybridized with cDNA
probe for hGAPDH (GAPDH). The upper panel shows
hybridization from one of three independent experiments. The
densitometric quantification of the three experiments is summarized in
the lower panel. For RS1, staining at 7.5 and 4.2 kb is
summarized. Signals that differ significantly from those obtained with
confluent cells grown with 5 mM D-glucose are
indicated (* p < 0.01; ** p < 0.001).
|
|
In Western blot analysis, the distribution of pSGLT1 and pRS1 proteins
was investigated after subcellular fractionation of LLC-PK1
cells that were grown until 2 days before or 5 days after confluence in
the presence of 5 mM D-glucose (Fig.
2a). pSGLT1 was detected with
the affinity-purified, subtype-specific antibody pSGLT1-ab (43) and
pRS1 with the affinity-purified antibody pRS1-ab that was raised
against recombinant pRS1 protein (29). In Western blots on purified
brush-border membranes from pig kidney, pSGLT1-ab binds to a
polypeptide band at about 75 kDa, whereas pRS1-ab detects a polypeptide
band at about 100 kDa (see control in Fig. 2a).
In control experiments, staining was abolished when the antibodies
SGLT1-ab and pRS1-ab were pre-absorbed with the antigenic SGLT1 peptide
or with purified pRS1 protein, respectively (29, 43). Whereas no
immunoreactivity for SGLT1 was observed in the cytosolic or endosomal
membrane fractions, SGLT1 was detected in the PME fraction (Fig.
2a, upper panel). In LLC-PK1 cells grown in 5 mM D-glucose, the concentration of SGLT1 in the
PME fraction was drastically increased after confluence (Fig. 2a,
upper panel). However, in the PME fraction of confluent cells
grown in 25 mM D-glucose, SGLT1 protein levels
were below the detection limit of our Western blot protocol (Fig.
2b). This confirms the above-described glucose-dependent down-regulation of SGLT1 and parallels
the transport data.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 2.
Western blot analysis of SGLT1 and RS1
protein in subconfluent and confluent LLC-PK1 cells grown
in low or high D-glucose. LLC-PK1 cells
were grown in 5 or 25 mM D-glucose and
harvested 2 days before or 5 days after confluence. From each
preparation, a plasma membrane-enriched fraction (PME), a
200,000 × g supernatant containing cytosolic proteins
(CY), and a fraction with endosomal membranes
(EN) were prepared. 15 µg of protein per lane of the
various fractions were subjected to SDS-polyacrylamide gel
electrophoresis. The proteins were transferred to nitrocellulose
membranes and immunolabeled with affinity-purified antibody against
pSGLT1 or against pRS1. a shows immunoreactions with
different subcellular fractions of subconfluent and confluent
LLC-PK1 cells grown with 5 mM
D-glucose. Porcine renal brush-border membranes served as a
control. b shows immunoreactions with pSGLT1 in PME
fractions that were isolated from confluent LLC-PK1 cells
grown in 25 or 5 mM D-glucose. c
immunoreactions with pRS1 are shown that were performed on PME
fractions isolated from subconfluent and confluent LLC-PK1
cells grown in 25 or 5 mM D-glucose.
|
|
At variance with porcine renal brush-border membranes where pRS1-ab
stained a single polypeptide band at 100 kDa (29), in the PME fraction
of LLC-PK1 cells, polypeptide bands were detected at about
100, 60, and in some cases also at about 90 kDa (Fig. 2, a
and c). In LLC-PK1 cells grown in 5 or 25 mM D-glucose, the concentration of RS1 protein
in the PME fraction was much higher before than after confluence (Fig.
2a, lower panel, and c). When the cells were
grown in 5 or 25 mM D-glucose, no difference in pRS1 protein was apparent before versus after confluence
(Fig. 2c). The data show that pRS1 protein concentration at the plasma membrane changes dramatically and opposite to the SGLT1 protein when
the cells have reached confluence. In contrast to SGLT1, the expression
level of RS1 protein at the plasma membrane is not affected by the
D-glucose concentration in the medium.
Overexpression of pRS1 in LLC-PK1 Cells--
To
investigate whether RS1 affects the expression of SGLT1, pRS1 was
overexpressed in LLC-PK1 cells. The cells were stably transfected with the pRcCMV vector containing the complete open reading
frame of pRS1 downstream to the CMV promoter (cell lines S10-S13).
LLC-PK1 cells stably transfected with the empty vector pRcCMV vector served as control (cell line CON3). Overexpression of
pRS1 protein was verified in Western blots on homogenates of LLC-PK1 cells that were grown for 5 days after confluence
in the presence of 5 mM D-glucose. The
1st lane of Fig. 3a
shows a control reaction with purified brush-border membrane of porcine
renal cortex. Whereas endogenous pRS1 protein was not detected in the homogenate of the control cell line (CON3 in Fig.
3a), in cell lines stably transfected with pRS1,
overexpressed pRS1 was stained as a 100-kDa band (S10-S13
in Fig. 3a). The cells overexpressing RS1 exhibited a
slightly higher proliferation rate as cell line CON3, reaching
confluence between 6 and 7 days after seeding (Fig. 3b).
After confluence, the cells overexpressing RS1 exhibited a little
higher cell density than the control cells (Fig. 3b). Eleven
days after seeding, total protein concentrations per cell were
0.65 ± 0.04 ng (CON3), 0.57 + 0.04 ng (S11), and 0.53 ± 0.03 ng (S12). In Fig. 3c, the activity of
Na+-D-glucose co-transport was compared in cell
lines overexpressing pRS1 (S10-S13), in native LLC-PK1
cells (native), and in LLC-PK1 cells that had been stably
transfected with the empty vector (CON3). The cells were grown with 5 mM D-glucose and harvested 5 days after
confluence, and initial uptake of 10 µM AMG was measured after 2.5 min of incubation in the presence and absence of 100 µM phlorizin. Fig. 3c shows that the
phlorizin-inhibitable AMG uptake rates in cell lines S10-S13 were
5-15 times smaller than those measured in native LLC-PK1
cells and in cell line CON3. To determine whether the reduced uptake in
RS1 overexpressing cells indicates a decrease of transporter affinity
or maximal transport rate, the substrate dependence was measured with
cell line S11. Fig. 3d shows that the maximal transport rate
in cell line S11 (0.17 ± 0.01 nmol × mg 1 × min 1) was about 10 times smaller than the maximal
transport rate in native LLC-PK1 cells that were grown
under the same conditions (upper panel of Fig. 7,
Vmax = 2.03 ± 0.05 nmol × mg 1 × min 1). The Km
value for AMG uptake by cell line S11 was 0.36 ± 0.07 mM. This is half the apparent Km value
of native LLC-PK1 cell lines grown and harvested under the
same conditions (upper panel of Fig. 7,
Km = 0.79 ± 0.04 mM). Because the
plasma membrane depolarizes during
Na+-D-glucose co-transport and the
Km value of SGLT1 for glucose increases with
decreasing membrane potential (46), the observed difference in
Km may be due to the stronger depolarization in the
more active native LLC-PK1 cells. The apparent Km value for AMG uptake by human SGLT1 expressed in
Xenopus oocytes was increased by a similar factor when the
membrane potential was decreased from 70 to 30 mV (46). To
determine whether the repression of SGLT1 expression after cultivation
with high D-glucose was preserved after overexpression of
pRS1, cell lines S11 and S12 were grown with 5 or 25 mM
D-glucose and harvested 5 days after confluence, and
phlorizin-inhibitable uptake of 10 µM AMG was measured
after 2.5 min of incubation. After growing S11 and S12 with 25 versus 5 mM D-glucose, AMG uptake
was decreased by 55 ± 20 and 75 ± 22%, respectively
(means ± S.D., n = 3, p < 0.01 for decrease of uptake). Because LLC-PK1 control cells showed about the same decrease of AMG uptake, the data suggest that the
repression of AMG uptake by pRS1 and by cultivation with high
D-glucose is additive.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Characterization of LLC-PK1 cell
lines that were stably transfected with pRS1. The Western blot in
a shows the expression of pRS1 protein in
LLC-PK1 cells stably transfected with pRS1. Homogenates
from LLC-PK1 cells that were stably transfected with the
pRcCMV vector containing pRS1 (lines S10-S13) are compared
with a homogenate from LLC-PK1 cells stably transfected
with the empty pRc/CMV vector (line CON3). 15 µg of protein were applied per lane, and the blots were developed
with affinity-purified antibody against pRS1 (pRS1-ab). The reaction of
pRS1-ab with porcine renal brush-border membranes (BBM) is
shown as a control. b, the growth curves of the
pRS1-overexpressing cell lines S11 and S12 are compared with that of
the control cell line CON3. Cells were seeded at a density of 4400 cells × cm 2 and cultivated with 5 mM
D-glucose in the medium. The cell density was determined
from 1 to 11 days after seeding. Confluence was observed on day 6 or 7. Mean values ± S.D. from four plates are presented. c,
the initial phlorizin-inhibitable uptake rates of 10 µM
[14C]AMG are compared in native LLC-PK1 cells
(native), in the control cell line CON3, and in
four cell lines overexpressing pRS1 (S10-S13). The uptake
measurements were performed with cells that were grown 5 days after
confluence in the presence of 5 mM D-glucose.
Phlorizin-inhibitable uptake rates ± S.D. from three culture
plates are illustrated. The data are derived from three different
experiments and are normalized to the uptake obtained in native
LLC-PK1 cells. d, the glucose dependence of the
phlorizin-inhibitable AMG uptake in the RS1-overexpressing cell line
S11 is demonstrated. The Michaelis-Menten equation was fit to the
data.
|
|
Next, we compared the amount of SGLT1 protein in PME fractions isolated
from cell lines CON3, S11, and S12 and the amount of cellular SGLT1
mRNA in these cell lines. For these experiments, the cells were
grown in 5 mM D-glucose and harvested 5 days
after confluence. The Western blot in the upper panel of
Fig. 4 shows that SGLT1 protein could be
detected in the PME fraction of line CON3 but was not detected in the
RS1-overexpressing cell lines S11 and S12. The Northern blots in the
lower panel of Fig. 4 show that the decrease of SGLT1
protein in cell lines S11 and S12 mainly reflects a difference in
mRNA concentrations. Compared with line CON3, the concentration of
SGLT1 mRNA was dramatically decreased in cell lines S11 and S12. In
contrast, the mRNA concentrations of another membrane-spanning
protein (the vasopressin receptor 2, V2R) and of a cytosolic protein
(glyceraldehydephosphate dehydrogenase, GAPDH) were not
changed.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Decrease of SGLT1 mRNA and SGLT1 protein
in LLC-PK1 cell lines that were stably transfected with
pRS1. The amounts of pSGLT1 protein (upper panel) and
pSGLT1 mRNA (lower panel) were compared in the control
cell line CON3 and the pRS1-overexpressing cell lines S11 and S12. The
cells were grown in the presence of 5 mM
D-glucose and harvested 5 days after confluence. The
Western blot in the upper panel was performed with plasma
membrane-enriched membrane fractions (PME) that were
isolated from the different cell lines. It was developed with the
affinity-purified antibody against pSGLT1 (pSGLT1-ab). The Northern
blots in the lower panel were hybridized with cDNA
probes specific for pSGLT1, glyceraldehydephosphate dehydrogenase
(GAPDH) or the vasopressin receptor type 2 (V2R).
|
|
Generation of LLC-PK1 Cell Lines Where the Expression
of Endogenous pRS1 Is Reduced--
To characterize further the effect
of pRS1 on the expression of SGLT1 related to confluence and
extracellular D-glucose concentration, an antisense
strategy was employed. We generated stably transfected LLC-PK1 cell lines that transcribe a 1.5-kb antisense
pRS1-cRNA fragment that covers the ATG start codon. Most measurements
were performed with cell lines containing antisense RS1 introduced with
the pRc/CMV vector (cell lines AS6 and AS8). Control experiments were
carried out with an LLC-PK1 cell line that was stably
transfected with the empty vector (cell line CON3), with native
LLC-PK1 cells, and with a LLC-PK1 cell line in
which a 1.2-kb antisense construct of the porcine oxytocin receptor was
stably expressed. Some experiments were also performed with an
LLC-PK1 cell line where antisense RS1 was stably
transfected with the pIND vector from Invitrogen (cell line AS2, see
Fig. 6). In this system the transcription of RS1 can be induced by
muristerone A (31). The characterization of the RS1 antisense cell
lines is shown in Fig. 5. PCR and reverse transcriptase-PCR experiments showed that antisense pRS1 DNA was incorporated in the genome of the transfected LLC-PK1 cell
lines (lanes d and e) and that it was transcribed
into antisense RS1 RNA (lanes l and m),
respectively. No reaction products were obtained with native
LLC-PK1 cells (lanes c and i) or with
cell line CON3 that had been stably transfected with the empty pRcCMV
vector (lane k). To determine the amount of pRS1 protein
associated with the plasma membrane, LLC-PK1 cells were
grown in the presence of 5 mM D-glucose until 2 days before reaching confluence. Then the respective PME fractions were
isolated, and pRS1 protein was analyzed by Western blots using
affinity-purified pRS1-ab. In line CON3, intact pRS1 protein and
additional proteolytic fragments were observed at ~60 and ~55 kDa
(lane o). In contrast, the antisense RS1 cell lines AS6 and
AS8 contained no intact pRS1 protein and largely reduced amounts of the
proteolytic fragments (lanes p and q).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 5.
Expression of pRS1 in LLC-PK1
cell lines that were stably transfected with antisense pRS1.
LLC-PK1 cell lines were stably transfected with the pRcCMV
vector containing antisense pRS1 (AS6 and AS8) or
with the empty vector (CON3). Five days after confluence,
genomic DNA (upper panel), mRNA (middle
panel), or the plasma membrane enriched fraction PME (lower
panel) were isolated. In polymerase chain reaction analysis,
fragments of RS1 were amplified directly (upper panel) or
after reverse transcription (middle panel). No specific
amplification was obtained with water (lanes b and
h), with DNA or RNA from native LLC-PK1 cells
(lanes c and i), or with RNA from the control
cell line CON3 (lane k). The upper panel shows
the genomic integration of antisense pRS1 in lines AS6 and
AS8. The transcription of the RS1 antisense fragment is
demonstrated in the middle panel. The lower panel
shows a Western blot of plasma membranes that were isolated from
porcine renal brush-border membranes (lanes n and
r), the control LLC-PK1 cell line CON3
(lane o), or from the pRS1 antisense cell lines AS6 and AS8
(lanes p and q). The antibody staining of pRS1
was performed with the affinity purified antibody pRS1-ab that
identifies intact pRS1 as a 100-kDa polypeptide band.
|
|
To test whether proliferation and/or cell size was altered in the
antisense pRS1 cell lines, we determined the cell density and protein
content 5 days after confluence. The antisense pRS1 cell lines, native
LLC-PK1 cells, and the control cell line CON3 all reached
confluence between 6 and 8 days after seeding. The cell densities
determined 5 days after reaching confluence were not significantly
different: native LLC-PK1 cells 1.3 ± 0.2, CON3 1.3 ± 0.2, AS6 0.9 ± 0.1, and AS8 1.0 ± 0.1 (× 105 cells/cm2, means ± S.D. from three
independent experiments). Similarly, the protein contents per cell were
not significantly different between cell lines: native
LLC-PK1 cells 0.71 ± 0.15, CON3 0.70 ± 0.15, AS6 0.64 ± 0.03, and AS8 0.84 ±+ 0.03 (ng/cell, means ± S.D., n = 3).
Na+-D-Glucose Co-transport Activity in RS1
Antisense Cell Lines--
First, we examined the initial rates of
phlorizin-inhibitable uptake of AMG in the pRS1 antisense cell lines as
compared with various control cell lines. As the expression of SGLT1 in
LLC-PK1 cells is lower when the cells are grown in 25 mM D-glucose as compared with 5 mM
D-glucose (17, 18), both conditions were tested. The
initial uptake rates of 40 µM [14C]AMG were
measured with suspended cells that had been grown until 5 days after
confluence. Fig. 6 (upper
panel) shows similar initial phlorizin-inhibitable glucose uptake
rates in three different control cell lines, i.e. in native
LLC-PK1 cells, in cell line CON3, which was stably
transfected with the empty pRcCMV vector, and in the uninduced pRS1
antisense cell line AS2. Five to ten times higher initial uptake rates
were observed in all three cell lines when cells were grown in the
presence of 5 mM D-glucose instead of 25 mM D-glucose. With an LLC-PK1 cell
line stably transfected with a 1.2-kb antisense construct of the
porcine oxytocin receptor, AMG uptake rates were obtained that were in
the range of the other control cell lines (data not shown). In the pRS1
antisense cell lines up-regulation of
Na+-D-glucose co-transport as compared with
controls was observed (lower panel). This effect was
dramatic in cells that were grown with 25 mM
D-glucose in the medium. It was smaller when the basal Na+-D-glucose co-transport activity was
increased during cultivation with 5 mM
D-glucose. Under this condition the up-regulation in cell
line AS6 was not statistically significant (Fig. 6). The smaller
up-regulation in the RS1 antisense cell lines after cultivation with 5 mM D-glucose compared with 25 mM
D-glucose may be due to a limited capacity of
LLC-PK1 cells to express
Na+-D-glucose co-transport activity.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of RS1 on the expression of
Na+-D-glucose co-transport in
LLC-PK1 cells grown in high or low glucose. Control
LLC-PK1 cells (upper panel) and pRS1 antisense
LLC-PK1 cells (lower panel) were grown with 25 mM D-glucose (shaded bars) or 5 mM D-glucose in the medium (open
bars). Five days after confluence, the cells were harvested and
washed in transport medium, and the initial uptake rates of 40 µM [14C]AMG were determined after 2.5 min
of incubation in the absence and presence of 100 µM
phlorizin. Phlorizin-inhibitable uptake rates are presented as mean
values ± S.E. of triplicate experiments. Native
LLC-PK1 cells (native), control cell line CON3,
non-induced cell line AS2 (AS2 uninduced), pRS1 antisense cell lines
AS6 and AS8, and the muristerone-induced RS1 antisense cell line AS2
(AS2 induced) were compared.
|
|
To distinguish whether the increase of AMG uptake in the pRS1 antisense
cell lines reflects an increase in Vmax or a
decrease of Km, the concentration dependence of AMG
uptake was compared in the antisense pRS1 cell line AS8 and native
LLC-PK1 cells. Fig. 7 shows
the concentration dependence of phlorizin-inhibitable [14C]AMG uptake in native LLC-PK1 cells and
line AS8 which were grown 5 days after reaching confluence with 5 or 25 mM D-glucose in the medium. The
Michaelis-Menten equation was fit to the data. The following
Vmax values (nmol × mg 1 × min 1) and apparent Km values
(mM) were calculated as follows: native cells in 25 mM D-glucose, Vmax = 0.30 ± 0.02, Km = 0.42 ± 0.07; native
cells in 5 mM D-glucose,
Vmax = 2.03 ± 0.05, Km = 0.79 ± 0.04; AS8 in 25 mM D-glucose,
Vmax = 5.61 ± 0.22, Km = 0.84 ± 0.07; AS8 in 5 mM D-glucose,
Vmax = 9.62 ± 0.73, Km = 1.01 ± 0.16. The 2-fold higher Km value in
native cells grown in 5 mM D-glucose as
compared with cells grown in 25 mM D-glucose is
probably due to a more pronounced membrane depolarization at higher
uptake rates of this electrogenic transporter as discussed above. Thus,
probably only the Vmax of AMG uptake is
decreased when native cells are grown with 25 instead of 5 mM D-glucose. Analogously, the data are
compatible with the notion that depletion of pRS1 entails an increase
in Vmax without changing the
Km value of AMG transport as shown by line AS8.
Comparing the Vmax values of AS8 cells grown in
the presence of 5 or 25 mM D-glucose in four
independent experiments revealed no significant difference (9.6 ± 0.8 versus 9.5 ±+ 3.0 pmol × mg 1 × min 1).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of RS1 on the substrate dependence of
Na+-D-glucose co-transport in
LLC-PK1 cells. Native LLC-PK1 cells
(upper panel) and cells of the pRS1 antisense cell line AS8
(lower panel) were grown in 25 mM
D-glucose (closed symbols) or with 5 mM D-glucose (open symbols). Five
days after confluence, the cells were harvested and analyzed for
initial rates of [14C]AMG uptake at different AMG
concentrations in the absence or presence of 100 µM
phlorizin as in Fig. 6. Mean values ± S.D. (n = 3) of phlorizin-inhibitable uptake rates are plotted versus
the AMG concentrations. The Michaelis-Menten equation was fit to the
data.
|
|
SGLT1 Protein in the Plasma Membrane of pRS1 Antisense Cell
Lines--
To determine whether the Vmax
increase of Na+-D-glucose co-transport in RS1
antisense cells is due to an increased number of SGLT1 transporters in
the plasma membrane, we assessed the amount of SGLT1 protein in the PME
fraction of LLC-PK1 cells by Western blotting using
affinity-purified pSGLT1-ab. In native LLC-PK1 cells
(upper lane of Fig. 2) and in the control line CON3 (data not shown), SGLT1 protein was only detectable in confluent cells. Five
days after reaching confluence of native cells or line CON3, the amount
of SGLT1 protein was significantly higher in cells grown in 5 mM D-glucose as compared with 25 mM
D-glucose (Figs. 2 and 8). In
confluent pRS1 antisense cells, the amount of SGLT1 protein in the PME
fraction was drastically increased under both conditions (Fig. 8,
upper panel). In the bottom panel of Fig. 8, the
staining of SGLT1 is shown for cell lines CON3 and AS8 that were grown
for 5 days after reaching confluence in 25 mM D-glucose. In line AS8, the amount of SGLT1 protein was
more than 20 times larger than in line CON3. The observation that the
increase of SGLT1 protein in RS1 antisense cell line AS8 was more
pronounced than the increase in Vmax of
Na+-D-glucose co-transport may be explained by
the presence of subapical membrane vesicles containing SGLT1 in the PME
fraction.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 8.
Effects of RS1 on the amount of SGLT1 protein
in the PME fraction of LLC-PK1 cells grown in high or low
glucose medium. Control LLC-PK1 cells
(CON3) and RS1 antisense cells (AS6 and AS8) were grown in
the presence of 5 mM D-glucose (5G)
or 25 mM D-glucose (25G) and
harvested 5 days after reaching confluence. PME fractions were isolated
and separated by SDS-polyacrylamide gel electrophoresis, and SGLT1
protein was analyzed in Western blots as in Fig. 2. In the upper
panel, each lane was loaded with 10 µg of protein. In the
lower panel, the indicated amounts of plasma membrane
protein were loaded.
|
|
Effect of RS1 on SGLT1 mRNA--
mRNA was isolated from
different LLC-PK1 cell lines grown in 25 and 5 mM D-glucose and hybridized with cDNA
probes specific for pSGLT1, GAPDH, or the vasopressin receptor V2R
(Fig. 9). Similar to native
LLC-PK1 cells (see Fig. 1), the 3.9- and the 2.2-kb transcripts of SGLT1 were decreased 3-fold in control cells CON3 (p < 0.001) when the cells were grown in 25 mM D-glucose as compared with 5 mM
D-glucose. This glucose-dependent decrease of
SGLT1 message was not observed for GAPDH and for the vasopressin
receptor V2R. In the RS1 antisense cell lines AS6 and AS8, the staining of both SGLT1 transcripts was increased in contrast to GAPDH and V2R.
The increase of SGLT1 mRNA was between 4- and 11-fold after culture
in 5 mM D-glucose (p < 0.05 for AS6 and p < 0.001 for AS8) and between 4- and
9-fold after culture in 25 mM D-glucose (p < 0.05 for AS6 and p < 0.001 for
AS8). In the antisense cell lines AS6 and AS8, the decrease in SGLT1
mRNA in 25 mM D-glucose as compared with 5 mM D-glucose was between 2- and 5-fold.
Statistical significance of the glucose-dependent decrease
of SGLT1 mRNA in AS6 and AS8 was only obtained when the staining of
both SGLT1 transcripts was summed up (p < 0.01 for
AS6, p < 0.05 for AS8).

View larger version (73K):
[in this window]
[in a new window]
|
Fig. 9.
Northern blot analysis of SGLT1, GAPDH, and
V2R in confluent RS1 antisense cell lines grown in low and high glucose
medium. Control LLC-PK1 cells (CON3) and
RS1 antisense cells (AS6 and AS8) were cultivated
in the presence of 5 or 25 mM D-glucose and
harvested 5 days after reaching confluence, and mRNAs were
prepared. 5 µg of mRNA per lane were separated on agarose gels in
the presence of glyoxal, blotted to nylon membranes, and hybridized
with radiolabeled cDNAs of pSGLT1 (SGLT1), human
glyceraldehydephosphate dehydrogenase (GAPDH), or the
porcine vasopressin receptor (V2R). For each gene four
hybridizations were performed employing separate agarose gels of two
independent cultivations. Typical autoradiographs are shown in which
the films were exposed for 8 h. The densitometric quantification
of the four hybridizations is summarized in the lower panel.
Hybridization signals are indicated that differ significantly from the
hybridization obtained with line CON3 grown with the respective glucose
concentration ( , p < 0.01; , p < 0.05). Comparing the cultivation with 5 and 25 mM
D-glucose, the staining differences in each of the two
SGLT1 transcripts in cell line CON3 were significantly different (*
p < 0.001). In cell lines AS6 and AS8, the staining
differences after cultivation in 5 and 25 mM
D-glucose were significantly different when the stainings
of both SGLT1 transcripts were summarized (p < 0.05).
|
|
To determine whether the effect of RS1 on SGLT1 expression is related
to confluence of the cells, we next investigated whether in the RS1
antisense cell lines SGLT1 mRNA was already increased before
confluence. In four independent experiments, cell lines CON3, AS6, and
AS8 were grown to about 60% confluence in the presence of 5 mM D-glucose. The mRNAs were isolated,
separated on agarose gels, and hybridized with cDNA probes specific
for pSGLT1 and GAPDH. Fig. 10 shows
that before confluence SGLT1 mRNA was not significantly increased
in the RS1 antisense cell lines. We also compared the
phlorizin-inhibitable uptake rates of 40 µM AMG in cell
lines CON3, AS6, and AS8 that were grown to 60% confluence in the
presence of 5 mM D-glucose or 25 mM
D-glucose. From three independent experiments the following
uptake rates (in pmol × mg protein 1 × min 1) were obtained: 5 mM
D-glucose 0.44 ± 0.08 (CON3), 0.48 ± 0.04 (AS6), 0.40 ± 0.09 (AS8); 25 mM D-glucose
0.36 ± 0.04 (CON3), 0.32 ± 0.04 (AS6), 0.32 ± 0.04 (AS8). The data show that the expression of SGLT1 is not significantly
different in subconfluent RS1 antisense and control LLC-PK1
cells irrespective as to whether they have been grown with 5 or 25 mM D-glucose. This indicates that the effect of
pRS1 only applies after polarization of LLC-PK1 cells.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 10.
Northern blot analysis of SGLT1 and GAPDH in
subconfluent RS1 antisense cell lines grown in low glucose.
Control cell line CON3 and the RS1 antisense LLC-PK1 cell
lines AS6 and AS8 were grown in 5 mM D-glucose
and harvested at about 60% confluence. Northern blots were performed
with radiolabeled cDNAs of pSGLT1 and hGAPDH as in Fig. 9. The
hybridizations were performed on four mRNA preparations from
independent experiments. In the upper panel a typical
autoradiograph is shown in which the film was exposed for 3 days. In
the lower panel the quantification of the experiments is
presented. No significant differences in hybridization between line
CON3 and lines AS6 or AS8 were detected.
|
|
A preliminary set of experiments was performed to evaluate whether the
RS1-dependent regulation of SGLT1 observed in confluent LLC-PK1 cells is specific for this plasma membrane
transporter. In Northern blots, the cDNA probes of two other plasma
membrane transporters, the Na+-independent glucose
transporter GLUT1 (35) and the polyspecific organic cation transporter
OCT2 (36), and a cDNA probe of the cytosolic protein ubiquitin were
hybridized to mRNAs isolated from cell lines CON3, AS6, and AS8.
The cell lines were grown 5 days after reaching confluence in the
presence of 5 mM D-glucose. The hybridization
signal of the Northern blots was quantified and normalized to the
signal of cell line CON3. From two independent experiments, the data
obtained with both RS1 antisense cell lines (AS6 and AS8) were
combined. The relative signal intensities of RS1 antisense cell lines
were 1.80 ± 0.17 for GLUT1, 1.19 ± 0.54 for OCT2 and
1.18 ± 0.22 for ubiquitin. The increase of GLUT1 mRNA in the
RS1 antisense cell lines was statistically significant (p < 0.01); however, it was much less pronounced than
the mRNA increase of SGLT1.
To investigate whether the effects of RS1 on SGLT1 mRNA
concentration represent changes in the rate of transcription or in message stability, we compared the degradation of the two SGLT1 mRNA transcripts in native LLC-PK1 cells and in RS1
antisense cell lines AS6 or AS8. The cells were grown with 5 mM D-glucose for 5 days after confluence. Then
25 µg/ml of the RNA polymerase II inhibitor DRB was added to the
medium, and the cells were harvested at time intervals between 1 and
20 h. Northern blots were performed and hybridized with SGLT1
cDNA. The two mRNA transcripts were quantified by densitometry.
Two independent experiments revealed that the message stability of the
SGLT1 transcripts in the RS1 antisense cell line was not changed
significantly (data not shown). These data suggest that the
transcription of SGLT1 is inhibited by RS1. To validate this
interpretation and to determine whether RS1 influences the
transcription of GLUT1 and OCT2, we performed nuclear run-on assays
with the control cell line CON3 and cell lines AS6 and AS8. For these
experiments, the cells were grown with 5 mM
D-glucose and harvested 5 days after confluence, and the
nuclei were isolated and washed. After 30 min of incubation of the
nuclei with radioactively labeled uridine triphosphate, the newly
synthesized mRNA was isolated and hybridized to membrane-bound cDNAs of hGLUT1, hOCT2, pSGLT1, and of a fragment of the
lacI gene which served as a control for nonspecific binding.
Identical results were obtained from two independent experiments
showing that the synthesis of SGLT1 mRNA in the RS1 antisense cell
lines AS6 and AS8 was significantly (p < 0.01)
increased by a factor of about 10 (Fig.
11). The synthesis of GLUT1 mRNA
was not changed significantly, whereas the synthesis of hOCT2 mRNA
was increased by a factor of 2 (p < 0.05).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 11.
Nuclear run-on assay in RS1 antisense
LLC-PK1 cells. LLC-PK1 cells stably
transfected with pRcCMV vector (CON3) or pRcCMV vector
containing antisense RS1 (AS6 and AS8) were grown
in the presence of 5 mM D-glucose and harvested
5 days after confluence. The nuclei were isolated and incubated with
ATP, GTP, CTP, and [ -32P]UTP for 30 min. The mRNAs
were isolated, and equal amounts of radioactive mRNAs were used to
hybridize purified cDNA fragments of hGAPDH, hGLUT1, hOCT2, LacI,
and pSGLT1 that were immobilized on nylon filters. The upper
panel shows an autoradiograph of one experiment. The staining of
this and a second independent experiment (four dots for each
gene and cell line) was quantified densitometrically. In the
lower panel the mean values ± S.D. of the signal
intensities are presented. Significant differences between line
CON3 and lines AS6 or AS8 are indicated (*
p < 0.05, **p < 0.01).
|
|
 |
DISCUSSION |
The amount of the Na+-D-glucose
co-transporter molecules in the plasma membrane may be changed within
minutes via endo- and exocytosis (14). In contrast, the transcriptional
regulation of SGLT1 is known to occur more slowly. The expression of
SGLT1 is altered via changes of intracellular mRNA concentrations
that were reported to be mediated by factors either directly affecting the transcription (11) or the stability of the mRNA (21, 25). When
LLC-PK1 cells grown in 5 mM
D-glucose differentiate during confluence, the cytosolic
concentration of SGLT1 mRNA increases. In contrast, SGLT1 mRNA
decreases when the cells de-differentiate after being detached
mechanically or by trypsin treatment (19, 22). In confluent
LLC-PK1 cells, the concentration of cytosolic SGLT1
mRNA is also dependent on the concentration of
D-glucose in the incubation medium (17). In the past, many
studies have been performed in LLC-PK1 cells to resolve the
mechanisms that underlie these mRNA changes. They identified a
correlation between the increase of SGLT1 mRNA during confluence
with an increase of the intracellular cAMP and showed that SGLT1
mRNA was increased by cAMP-elevating agents (22). Furthermore, it
was revealed that the cAMP-dependent increase of SGLT1
mRNA relied on a decelerated message degradation that was mediated
by binding of a cytosolic protein to a defined 3' region of mRNA
(21, 25). In addition, it was found that the decrease of SGLT1 mRNA
during de-differentiation can be blocked or accelerated by inhibition
or stimulation of protein kinase C, respectively (19). Concerning the
regulation of SGLT1 in LLC-PK1 cells, many questions have
remained unsolved. For example, it is not known which signaling
mechanisms underlie the up-regulation of SGLT1 when LLC-PK1
cells are gaining confluence, which cellular events induce the decrease
of SGLT1 message during de-differentiation of the LLC-PK1
cells, and how protein kinase C affects the concentration of SGLT1 mRNA.
In this paper, we present data that show that the previously cloned
67-kDa polypeptide RS1 (26) is involved in transcriptional regulation
of the Na+-D-glucose co-transporter SGLT1 in
LLC-PK1 cells. We generated stably transfected
LLC-PK1 cell lines that either overexpress RS1 or
transcribe antisense mRNA of RS1 and thereby suppress the translation of endogenous RS1. Opposite effects were obtained by both
maneuvers. In the cell lines overexpressing RS1, SGLT1 mRNA, SGLT1
protein, and the Na+-D-glucose co-transport
activities were decreased, whereas in RS1 antisense cell lines message,
protein, and Na+-D-glucose transport activities
were dramatically increased. Because the stability of SGLT1 mRNA
was not significantly changed in RS1 antisense cells and the
transcription of SGLT1 was largely increased in a nuclear run-on assay,
our data suggest that RS1 is involved in the repression of SGLT1
transcription. Some selectivity for SGLT1 of this RS1 effect is
proposed because the transcription of GAPDH and GLUT1 was not changed
in the RS1 antisense cell lines, and the observed increase in
transcription of the organic cation transporter OCT2 was much smaller
than that of SGLT1. Interestingly, in the RS1 antisense cell lines, the
message of SGLT1 was only increased when the cells were grown until
after confluence. This indicates that RS1-mediated effects upon SGLT1
expression only apply in polarized cells forming a closed monolayer.
Depletion of RS1 in subconfluent cells is not sufficient to initiate
the up-regulation of SGLT1 but RS1 may act in concert with other
factors that are involved in the confluence-dependent
up-regulation of SGLT1. Because the concentration of RS1 at the plasma
membrane was drastically reduced after confluence, RS1 may play an
important role during this regulation.
Our data suggest that RS1 does not participate in the
glucose-dependent down-regulation of SGLT1 in
LLC-PK1 cells. After cultivation of LLC-PK1
cells with 25 mM D-glucose versus 5 mM D-glucose, glucose transport by SGLT1 was
reduced to a similar extent in controls and pRS1-overexpressing cells.
Also, after cultivation with 25 mM D-glucose
versus 5 mM D-glucose, SGLT1
mRNA was reduced to a similar extent in controls and RS1 antisense
LLC-PK1 cells. In controls and RS1 antisense cells, the
decrease of SGLT1 mRNA was correlated with a decrease of SGLT1
protein in a plasma membrane-enriched membrane fraction. The finding
that the glucose-induced decrease of SGLT1 protein in the RS1 antisense
cells was not combined with a significant decrease of the maximal
D-glucose transport rate, as observed in control cells, is
probably due to a limited capacity of the plasma membrane for
functional active transporter molecules.
To avoid over-interpretation of the data, it must be kept in mind that
stable overexpression or reduction of RS1 by antisense strategies may
lead to complex changes in the cells. For example, concentration and
activity of intracellular regulatory proteins and second messengers may
change. Even the increase in the transcription of SGLT1 in isolated
nuclei can rather be an effect that is mediated by the up-regulation or
activation of cytosolic proteins that are translocated into the nucleus
and activate transcription. However, since opposite effects were
obtained after overexpressing RS1 and reducing endogenous RS1 in our
stably transfected cell lines, and since we have recently been able to
demonstrate that RS1 actually migrates into the
nucleus,2 we hypothesize that
RS1 is a plasma membrane-associated protein that migrates into the
nucleus to act as an inhibitory transcription factor for SGLT1.
To discuss further the function of RS1, previous data must be recalled
and re-evaluated. We identified porcine RS1 (pRS1) after screening an
expression library with a monoclonal antibody raised against renal
brush-border membrane proteins (26), and we cloned proteins with amino
acid identities of 74 and 65% from human (hRS1) and rabbit (rbRS1),
respectively (28, 45). RS1 is a rather hydrophilic protein with two
conserved consensus sequences for protein kinase C, three conserved
consensus sequences for casein kinase II, and a conserved C terminus of
42 amino acids that contains a consensus sequence for a
ubiquitin-associated domain (47, 48) and a short hydrophobic -helix
at the C-terminal end (26). We showed that hRS1 is an intronless single
copy gene that localizes to chromosome 1.p36.1 (45). Performing
labeling experiments with membrane-impermeant reagents on oocytes of
Xenopus laevis expressing RS1, we recently localized RS1 to
the intracellular side of the plasma membrane (29). Functional activity
of RS1 was originally concluded from effects that were observed when RS1 was expressed after cRNA injection into Xenopus oocytes
(26, 28, 45). When RS1 was expressed alone, the membrane surface area
was reduced (29), and after co-expression of hRS1 with human SGLT1, the
Vmax of expressed glucose co-transport and the amount of expressed SGLT1 protein in the plasma membrane were decreased
(28, 45). The effect of RS1 on the expression of SGLT1 in X. oocytes is not specific for this plasma membrane transporter as
originally assumed (26) because the transport activity expressed by the
human cation transporter OCT2 was also reduced upon co-expression with
RS1 (28). However, it apparently does not concern all plasma membrane
proteins because the expression of some other plasma membrane
transporters was not changed (26). The effects of RS1 observed in
Xenopus oocytes probably represent functional activity of
RS1 protein at the plasma membrane that is independent of
transcription. First, in the employed oocyte expression system, RS1 and
SGLT1 were expressed by the injection of their cRNAs. Second, identical results were obtained when the experiments were performed in the absence or presence of the transcription blocker actinomycin
D.3 Possible functions of RS1
at the plasma membrane are an involvement in endo- or exocytosis or an
involvement in the degradation of a subset of plasma membrane transporters.
Further experiments are required to determine how RS1 is activated at
the plasma membrane and by what mechanism RS1 exhibits the described
effects on the transcription of SGLT1. The disappearance of RS1 during
confluence of LLC-PK1 cells suggests an activation of RS1
that may occur at the plasma membrane. A similar type of dual function
has been reported for -catenin. On the one hand, -catenin links
cadherin in adhesion receptors to the actin cytoskeleton, and on the
other hand it stimulates gene expression by binding to transcription
factors (49). The proposed function of RS1 has also similarities to the
sterol regulatory element-binding protein pathway where the metabolism
of cholesterol is regulated by a sterol-dependent release
of transcription factors called sterol regulatory element-binding
proteins from the endoplasmic reticulum (50). It will be a challenge to
characterize further the regulatory pathway of RS1 and to identify
physiological regulations that involve RS1.
 |
ACKNOWLEDGEMENT |
We thank Michael Christof for preparing the figures.
 |
FOOTNOTES |
*
This work was supported by the Deutsche
Forschungsgemeinschaft Grant SFB 487/C1.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to this work.
§
To whom correspondence should be addressed: Anatomisches Institut,
Koellikerstr. 6, 97070 Würzburg, Germany. Fax: 0931 312087; E-mail: Hermann@Koepsell.de.
Published, JBC Papers in Press, September 18, 2001, DOI 10.1074/jbc.M105975200
2
T. Kühlkamp, K. Baumgarten, M. Akimjanova,
V. Gorboulev, and H. Koepsell, manuscript in preparation.
3
M. Veyhl and H. Koepsell, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
DMEM, Dulbecco's
modified Eagle's medium;
DPBS, Dulbecco's phosphate-buffered saline;
PCR, polymerase chain reaction;
nt, nucleotides;
DRB, 5,6-dichloro-1- -D-ribofuranosylbenzimidazole;
PMSF, phenylmethylsulfonyl fluoride;
AMG, methyl- -D-glucopyranoside;
kb, kilobase pair;
bp, base
pair;
GAPDH, glyceraldehydphosphate dehydrogenase;
hGAPDH, human GAPDH;
PME, plasma membrane-enriched;
V2R, vasopressin receptor 2;
CMV, cytomegalovirus.
 |
REFERENCES |
| 1.
|
Hediger, M. A.,
and Rhoads, D. B.
(1994)
Physiol. Rev.
74,
993-1026
|
| 2.
|
Bell, G. I.,
Burant, C. F.,
Takeda, J.,
and Gould, G. W.
(1993)
J. Biol. Chem.
268,
19161-19164
|
| 3.
|
Klip, A.,
Tsakiridis, T.,
Marette, A.,
and Ortiz, P. A.
(1994)
FASEB
8,
43-53
|
| 4.
|
Pessin, J. E.,
and Bell, G. I.
(1992)
Annu. Rev. Physiol.
54,
911-930
|
| 5.
|
James, D. E.,
Piper, R. C.,
and Slot, J. W.
(1994)
Trends Cell Biol.
4,
120-126
|
| 6.
|
Ferraris, R. P.,
and Diamond, J.
(1992)
Am. J. Physiol.
262,
G1069-G1073
|
| 7.
|
Shirazi-Beechey, S. P.,
Hirayama, B. A.,
Wang, Y.,
Scott, D.,
Smith, M. W.,
and Wright, E. M.
(1991)
J. Physiol. (Lond.)
437,
699-708
|
| 8.
|
Oku, A.,
Ueta, K.,
Arakawa, K.,
Ishihara, T.,
Nawano, M.,
Kuronuma, Y.,
Matsumoto, M.,
Saito, A.,
Tsujihara, K.,
Anai, M.,
Asano, T.,
Kanai, Y.,
and Endou, H.
(1999)
Diabetes
48,
1794-1800
|
| 9.
|
Ayo, S. H.,
Radnik, R.,
Garoni, J. A.,
Troyer, D. A.,
and Kreisberg, J. I.
(1991)
Am. J. Physiol.
261,
F571-F577
|
| 10.
|
Heilig, C. W.,
Concepcion, L. A.,
Riser, B. L.,
Freytag, S. O.,
Zhu, M.,
and Cortes, P.
(1995)
J. Clin. Invest.
96,
1802-1814
|
| 11.
|
Rhoads, D. B.,
Rosenbaum, D. H.,
Unsal, H.,
Isselbacher, K. J.,
and Levitsky, L. L.
(1998)
J. Biol. Chem.
273,
9510-9516
|
| 12.
|
Ishikawa, Y.,
Eguchi, T.,
and Ishida, H.
(1997)
Biochim. Biophys. Acta
1357,
306-318
|
| 13.
|
Cheeseman, C. I.
(1997)
Am. J. Physiol.
273,
R1965-R1971
|
| 14.
|
Hirsch, J. R.,
Loo, D. D. F.,
and Wright, E. M.
(1996)
J. Biol. Chem.
271,
14740-14746
|
| 15.
|
Hull, R. N.,
Cherry, W. R.,
and Weaver, G. W.
(1976)
In Vitro
12,
670-677
|
| 16.
|
Amsler, K.,
and Cook, J. S.
(1982)
Am. J. Physiol.
242,
C94-C101
|
| 17.
|
Ohta, T.,
Isselbacher, K. J.,
and Rhoads, D. B.
(1990)
Mol. Cell. Biol.
10,
6491-6499
|
| 18.
|
Moran, A.,
Turner, R. J.,
and Handler, J. S.
(1983)
J. Biol. Chem.
258,
15087-15090
|
| 19.
|
Shioda, T.,
Ohta, T.,
Isselbacher, K. J.,
and Rhoads, D. B.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
11919-11923
|
| 20.
|
Peng, H.,
and Lever, J. E.
(1995)
J. Biol. Chem.
270,
23996-24003
|
| 21.
|
Peng, H.,
and Lever, J. E.
(1995)
J. Biol. Chem.
270,
20536-20542
|
| 22.
|
Yet, S. F.,
Kong, C. T.,
Peng, H.,
and Lever, J. E.
(1994)
J. Cell. Physiol.
158,
506-512
|
| 23.
|
Lasheras, C.,
Scott, J. A.,
and Rabito, C. A.
(1988)
Am. J. Physiol.
255,
C745-C753
|
| 24.
|
Amsler, K.,
Ghatani, S.,
and Hemmings, B. A.
(1991)
Am. J. Physiol.
260,
C1290-C1299
|
| 25.
|
Lee, W. Y.,
Loflin, P.,
Clancey, C. J.,
Peng, H.,
and Lever, J. E.
(2000)
J. Biol. Chem.
275,
33998-34008
|
| 26.
|
Veyhl, M.,
Spangenberg, J.,
Püschel, B.,
Poppe, R.,
Dekel, C.,
Fritzsch, G.,
Haase, W.,
and Koepsell, H.
(1993)
J. Biol. Chem.
268,
25041-25053
|
| 27.
|
Haase, W.,
Heitmann, K.,
Friese, W.,
Ollig, D.,
and Koepsell, H.
(1990)
Eur. J. Cell Biol.
52,
297-309
|
| 28.
|
Reinhardt, J.,
Veyhl, M.,
Wagner, K.,
Gambaryan, S.,
Dekel, C.,
Akhoundova, A.,
Korn, T.,
and Koepsell, H.
(1999)
Biochim. Biophys. Acta
1417,
131-143
|
| 29.
|
Valentin, M.,
Kühlkamp, T.,
Wagner, K.,
Krohne, G.,
Arndt, P.,
Baumgarten, K.,
Weber, W.-M.,
Segal, A.,
Veyhl, M.,
and Koepsell, H.
(2000)
Biochim. Biophys. Acta
1468,
367-380
|
| 30.
|
Kimmich, G. A.,
Randles, J.,
and Wilson, J.
(1994)
Am. J. Physiol.
267,
C1119-C1129
|
| 31.
|
No, D.,
Yao, T.-P.,
and Evans, R. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
3346-3351
|
| 32.
|
Cress, W. D.,
and Triezenberg, S. J.
(1991)
Science
251,
87-90
|
| 33.
|
Chomczynski, P.,
and Sacchi, N.
(1987)
Anal. Biochem.
162,
156-159
|
| 34.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 35.
|
Mueckler, M.,
and Lodish, H. F.
(1986)
Cell
44,
629-637
|
| 36.
|
Gorboulev, V.,
Ulzheimer, J. C.,
Akhoundova, A.,
Ulzheimer-Teuber, I.,
Karbach, U.,
Quester, S.,
Baumann, C.,
Lang, F.,
Busch, A. E.,
and Koepsell, H.
(1997)
DNA Cell Biol.
16,
871-881
|
| 37.
|
Gorbulev, V.,
Büchner, H.,
Akhundova, A.,
and Fahrenholz, F.
(1993)
Eur. J. Biochem.
215,
1-7
|
| 38.
|
Farrell, C. R.,
Boado, R. J.,
and Pardridge, W. M.
(1992)
Mol. Brain Res.
15,
221-226
|
| 39.
|
Tanaka, T.,
Kishi, K.,
Igawa, M.,
Takase, S.,
and Goda, T.
(1998)
Biochem. J.
331,
225-230
|
| 40.
|
Moran, A.,
Handler, J. S.,
and Turner, R. J.
(1982)
Am. J. Physiol.
243,
C293-C298
|
| 41.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 42.
|
Towbin, H.,
Staehelin, T.,
and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354
|
| 43.
|
Poppe, R.,
Karbach, U.,
Gambaryan, S.,
Wiesinger, H.,
Lutzenburg, M.,
Kraemer, M.,
Witte, O. W.,
and Koepsell, H.
(1997)
J. Neurochem.
69,
84-94
|
| 44.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
|
| 45.
|
Lambotte, S.,
Veyhl, M.,
Köhler, M.,
Morrison-Shetlar, A. I.,
Kinne, R. K. H.,
Schmid, M.,
and Koepsell, H.
(1996)
DNA Cell Biol.
15,
769-777
|
| 46.
|
Hirayama, B. A.,
Lostao, M. P.,
Panayotova-Heiermann, M.,
Loo, D. D. F.,
Turk, E.,
and Wright, E. M.
(1996)
Am. J. Physiol.
270,
G919-G926
|
| 47.
|
Dieckmann, T.,
Withers-Ward, E. S.,
Jarosinski, M. A.,
Liu, C. F.,
Chen, I. S.,
and Feigon, J.
(1998)
Nat. Struct. Biol.
5,
1042-1047
|
| 48.
|
Schultz, J.,
Milpetz, F.,
Bork, P.,
and Ponting, C. P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5857-5864
|
| 49.
|
Ben-Ze'ev, A.,
and Geiger, B.
(1998)
Curr. Opin. Cell. Biol.
10,
629-639
|
| 50.
|
Brown, M. S.,
and Goldstein, J. L.
(1997)
Cell
89,
331-340
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. J. Lee, J. S. Heo, H. N. Suh, M. Y. Lee, and H. J. Han
Interleukin-6 stimulates {alpha}-MG uptake in renal proximal tubule cells: involvement of STAT3, PI3K/Akt, MAPKs, and NF-{kappa}B
Am J Physiol Renal Physiol,
October 1, 2007;
293(4):
F1036 - F1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vernaleken, M. Veyhl, V. Gorboulev, G. Kottra, D. Palm, B.-C. Burckhardt, G. Burckhardt, R. Pipkorn, N. Beier, C. van Amsterdam, et al.
Tripeptides of RS1 (RSC1A1) Inhibit a Monosaccharide-dependent Exocytotic Pathway of Na+-D-Glucose Cotransporter SGLT1 with High Affinity
J. Biol. Chem.,
September 28, 2007;
282(39):
28501 - 28513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kroiss, M. Leyerer, V. Gorboulev, T. Kuhlkamp, H. Kipp, and H. Koepsell
Transporter regulator RS1 (RSC1A1) coats the trans-Golgi network and migrates into the nucleus
Am J Physiol Renal Physiol,
December 1, 2006;
291(6):
F1201 - F1212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Veyhl, T. Keller, V. Gorboulev, A. Vernaleken, and H. Koepsell
RS1 (RSC1A1) regulates the exocytotic pathway of Na+-D-glucose cotransporter SGLT1
Am J Physiol Renal Physiol,
December 1, 2006;
291(6):
F1213 - F1223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Jiang, O. Prokopenko, L. Wong, M. Inouye, and O. Mirochnitchenko
IRIP, a New Ischemia/Reperfusion-Inducible Protein That Participates in the Regulation of Transporter Activity
Mol. Cell. Biol.,
August 1, 2005;
25(15):
6496 - 6508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Osswald, K. Baumgarten, F. Stumpel, V. Gorboulev, M. Akimjanova, K.-P. Knobeloch, I. Horak, R. Kluge, H.-G. Joost, and H. Koepsell
Mice without the Regulator Gene Rsc1A1 Exhibit Increased Na+-D-Glucose Cotransport in Small Intestine and Develop Obesity
Mol. Cell. Biol.,
January 1, 2005;
25(1):
78 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Bormans, G. Van Oosterwyck, T. J. de Groot, M. Veyhl, L. Mortelmans, A. M. Verbruggen, and H. Koepsell
Synthesis and Biologic Evaluation of 11C-Methyl-D-Glucoside, a Tracer of the Sodium-Dependent Glucose Transporters
J. Nucl. Med.,
July 1, 2003;
44(7):
1075 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|